» Articles » PMID: 22695507

Distinct Roles of Central and Peripheral Prostaglandin E2 and EP Subtypes in Blood Pressure Regulation

Overview
Journal Am J Hypertens
Date 2012 Jun 15
PMID 22695507
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Prostaglandin E(2) (PGE(2)) is a major prostanoid with a wide variety of biological activities. PGE(2) can influence blood pressure (BP) both positively and negatively. In particular, centrally administered PGE(2) induces hypertension whereas systemic administration of PGE(2) produces a hypotensive effect. These physiologically opposing effects are generated by the existence of multiple EP receptors, namely EP(1-4), which are G protein-coupled receptors with distinct signaling properties. This review highlights the distinct roles of PGE(2) in BP regulation and the involvement of specific EP receptor subtypes.

Citing Articles

Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.

Zeng C, Liu J, Zheng X, Hu X, He Y Respir Res. 2023; 24(1):263.

PMID: 37915044 PMC: 10619262. DOI: 10.1186/s12931-023-02559-3.


Perivascular Adipose Tissue and Vascular Smooth Muscle Tone: Friends or Foes?.

Ahmed A, Bibi A, Valoti M, Fusi F Cells. 2023; 12(8).

PMID: 37190105 PMC: 10136477. DOI: 10.3390/cells12081196.


Cell-Specific Actions of the Prostaglandin E-Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages.

Yang T, Song C, Ralph D, Andrews P, Sparks M, Koller B J Am Heart Assoc. 2022; 11(19):e026581.

PMID: 36172956 PMC: 9673718. DOI: 10.1161/JAHA.122.026581.


Genetic Modifications to Alter Blood Pressure Level.

Ohara H, Nabika T Biomedicines. 2022; 10(8).

PMID: 36009402 PMC: 9405136. DOI: 10.3390/biomedicines10081855.


Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure.

Wang L, Wu Y, Jia Z, Yu J, Huang S Front Endocrinol (Lausanne). 2022; 13:875425.

PMID: 35813612 PMC: 9262144. DOI: 10.3389/fendo.2022.875425.


References
1.
Huerta C, Rodriguez L . Incidence of ocular melanoma in the general population and in glaucoma patients. J Epidemiol Community Health. 2001; 55(5):338-9. PMC: 1731887. DOI: 10.1136/jech.55.5.338. View

2.
Lawrence R, Jones R . Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br J Pharmacol. 1992; 105(4):817-24. PMC: 1908720. DOI: 10.1111/j.1476-5381.1992.tb09063.x. View

3.
Foudi N, Kotelevets L, Louedec L, Leseche G, Henin D, Chastre E . Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. Br J Pharmacol. 2008; 154(8):1631-9. PMC: 2518470. DOI: 10.1038/bjp.2008.214. View

4.
Orie N, Clapp L . Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors. Eur J Pharmacol. 2010; 654(3):258-65. DOI: 10.1016/j.ejphar.2010.12.005. View

5.
Jania L, Chandrasekharan S, Backlund M, Foley N, Snouwaert J, Wang I . Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat. 2008; 88(3-4):73-81. PMC: 3182462. DOI: 10.1016/j.prostaglandins.2008.10.003. View